CpG oligodeoxynucleotides (CpG ODN) offer immunostimulatory agents that elevate the penetration of immune cells into tumor microenvironments (TEM) by attaching to Toll-like receptor 9 (TLR-9) in the endosome. This evidence concerns the gene TLR9 and neoplasm.